Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Nuvalent, Inc.

NUVLNASDAQ
Healthcare
Biotechnology
$97.93
$-0.07(-0.07%)
U.S. Market opens in 14h 36m

Nuvalent, Inc. (NUVL) Stock Overview

Explore Nuvalent, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.2B
P/E Ratio-17.27
EPS (TTM)$-5.85
ROE-0.42%
Fundamental Analysis

AI Price Forecasts

1 Month$95.15
3 Months$88.24
1 Year Target$122.74

NUVL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nuvalent, Inc. (NUVL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.06, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $122.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -17.27 and a market capitalization of 7.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.07%
5-Day Change
-0.03%
1-Month Change
-2.87%
3-Month Change
-6.56%
6-Month Change
21.70%
Year-to-Date (YTD) Change
-2.89%
1-Year Change
31.48%
3-Year Change
246.65%
5-Year Change
422.29%
All-Time (Max) Change
422.29%

Contact Information

857 357 7000
One Broadway, Cambridge, MA, 02142

Company Facts

1,620 Employees
IPO DateJul 29, 2021
CountryUS
Actively Trading

Frequently Asked Questions